OA12.07 Clinical Activity of LOXO-292, a Highly Selective RET Inhibitor, in Patients with RET Fusion+ Non-Small Cell Lung Cancer
Geoffrey R. Oxnard,
Vivek Subbiah,
K. Park,
Todd M. Bauer,
Lori J. Wirth,
Vamsidhar Velcheti,
Manisha H. Shah,
Benjamin Besse,
Valentina Boni,
Karen L. Reckamp,
Journal of Thoracic Oncology · 2018 · 29 citations · 0 references